Document Detail


Does 1,25-dihydroxyvitamin D participate in the regulation of hormone release from endocrine glands?
MedLine Citation:
PMID:  2981087     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The presence of receptors for 1,25-dihydroxyvitamin D3 in the pituitary, pancreas, testis, and ovary has raised the question of a possible direct role for 1,25-dihydroxyvitamin D (1,25(OH)2D) in the regulation of hormone synthesis and secretion. To evaluate this problem, six children with the syndrome of resistance to 1,25(OH)2D with rickets and alopecia underwent dynamic tests of insulin, TSH, PRL, GH, and testosterone secretion. Oral glucose loading resulted in normal glucose curves, subnormal peak insulin responses of 12-20 microU/ml in three hypocalcemic patients, and normal peak serum insulin values of 30-40 microU/ml in two normocalcemic patients. Basal serum, TSH, PRL, T4, and T3 concentrations were normal in all patients. Peak serum TSH values after TRH were 11-17 and 16-32 microU/ml in the hypo- and normocalcemic patients, respectively. The PRL response to TRH stimulation in either hypocalcemic or normocalcemic patients was normal [mean 26.2 +/- 5.1 (SD) ng/ml]. Peak serum GH levels were greater than 8 ng/ml in all five patients studied after one or more of the various stimuli. Serum testosterone concentrations after hCG stimulation were normal in the three patients studied (4.1-8.0 ng/ml). Thus, in children with resistance to 1,25(OH)2D, we could find no significant abnormalities in hormone secretion from the pituitary, pancreas, and testis apart from those presumably due to the hypocalcemia itself.
Authors:
Z Hochberg; Z Borochowitz; A Benderli; P Vardi; S Oren; Z Spirer; I Heyman; Y Weisman
Related Documents :
2739137 - Effect of aminophylline injection on the pituitary-thyroid axis in asthmatics.
6808537 - Delayed tsh release in anorexia nervosa following injection of thyrotropin-releasing ho...
4199417 - Repetitive administration of thyrotropin-releasing hormone results in small elevations ...
22982787 - Significant attenuation of stimulated cortisol in early graves' disease without adrenal...
15972027 - Challenge-induced plasma exudation and mucinous secretion in human airways.
9266837 - Effect of enteral versus parenteral nutrition on leptin gene expression and release int...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The Journal of clinical endocrinology and metabolism     Volume:  60     ISSN:  0021-972X     ISO Abbreviation:  J. Clin. Endocrinol. Metab.     Publication Date:  1985 Jan 
Date Detail:
Created Date:  1985-01-23     Completed Date:  1985-01-23     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0375362     Medline TA:  J Clin Endocrinol Metab     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  57-61     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Calcitriol / physiology*
Calcium / blood
Child
Child, Preschool
Chorionic Gonadotropin / diagnostic use
Clonidine / diagnostic use
Endocrine Glands / secretion*
Female
Fibroblasts / metabolism
Glucose Tolerance Test
Growth Hormone / blood
Hormones / secretion*
Humans
Hypophosphatemia, Familial / metabolism*
Infant
Insulin / blood
Levodopa / diagnostic use
Male
Prolactin / blood
Receptors, Calcitriol
Receptors, Steroid / metabolism
Testosterone / blood
Thyrotropin / blood
Thyrotropin-Releasing Hormone / diagnostic use
Chemical
Reg. No./Substance:
0/Chorionic Gonadotropin; 0/Hormones; 0/Levodopa; 0/Receptors, Calcitriol; 0/Receptors, Steroid; 11061-68-0/Insulin; 24305-27-9/Thyrotropin-Releasing Hormone; 32222-06-3/Calcitriol; 4205-90-7/Clonidine; 58-22-0/Testosterone; 7440-70-2/Calcium; 9002-62-4/Prolactin; 9002-71-5/Thyrotropin; 9002-72-6/Growth Hormone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Oxytocin does not influence adrenocorticotropin secretion in man.
Next Document:  Effects of enalapril, a new angiotensin-converting enzyme inhibitor, in a controlled trial in heart ...